Bcel stock forecast.

Stock Price Forecast. The 8 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 55.00 and a low estimate of 20.00 ...

Bcel stock forecast. Things To Know About Bcel stock forecast.

Find the latest Atreca, Inc. (BCEL) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Analyst projections state that BCEL is forecast to be at a low of $1.00 and a high of $9.00. In order for the stock price to hit the forecast high, the stock would need to plunge -3361.54% from its current level, while the stock would need to crash -284.62% from its current level to reach the projected low. Atreca Inc (BCEL) estimates and forecastsScience. Atreca Inc (NASDAQ:BCEL)’s traded shares stood at 0.33 million during the last session, with the company’s beta value hitting 1.24. At the close of trading, the stock’s price was $0.21. The BCEL share’s 52-week high remains $2.05, putting it -876.19% down since that peak but still an impressive 9.52% since price per share fell ...BCEL Stock Analysis Overview What this means: InvestorsObserver gives Atreca Inc Cl A (BCEL) an overall rank of 35, which is below average. Atreca Inc Cl A is in the bottom …Forecst.com predicts future values using technical analysis of a large number of analytical parameters. BCLI stock returns are also predicted based on historical data. According to our research, BCLI stock is a bad long-term investment. BCLI share price has been in a bear cycle for the past year.

See Atreca, Inc. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. ... The 4 analysts offering 1 year …

Atreca Inc (NASDAQ:BCEL) 0.2302. Delayed Data. As of Nov 30. +0.0047 / +2.19%. Today’s Change. 0.19. Today ||| 52-Week Range. 2.05.Next reporting date. December 19, 2023. EPS forecast (this quarter) -$0.08. Annual revenue (last year) $130.5M. Annual profit (last year) -$142.7M. Net profit margin.

Earnings announcement* for BCEL: Our vendor, Zacks Investment Research, hasn't provided us with the upcoming earnings report date. BCEL has a "high" Earnings Quality Ranking (EQR) for the 5th ...QFIN Stock 12 Months Forecast. $25.75. (85.12% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Qifu Technology in the last 3 months. The average price target is $25.75 with a high forecast of $27.00 and a low forecast of $24.50. The average price target represents a 85.12% change from the last price of $13.91.Read Full Company Summary for SBOW here. View SilverBow Resources SBOW investment & stock information. Get the latest SilverBow Resources SBOW detailed stock quotes, stock data, Real-Time ECN ...Learn more about Atreca Inc's (BCEL) stock grades for Momentum, Growth and Estimate Revisions and determine whether this Biotechnology & Medical Research stock meets your investment needs. ... The Biotechnology and Medical Research sub-industry has a positive outlook, a historically defensive sub-industry. Drug sales are …

The above table shows the analyst BCEL forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$0.22

Stock Price Forecast. The 17 analysts offering 12-month price forecasts for BCE Inc have a median target of 41.19, with a high estimate of 45.64 and a low estimate of 39.16. The median estimate ...

The shares of micro-cap biotech, Atreca (BCEL +46.1%) have added more than a third in morning hours on Friday after the company updated early-stage data for its lead cancer candidate ATRC-101 with ...BCEL is currently rated as a Sucker Stock | Stockopedia. Login Get Started. Sectors Healthcare Biotechnology & Medical Research Atreca. ... Is there a Atreca share price forecast for 2023? The analyst consensus target price for shares in Atreca is $3.25. That is 1420.11% above the last closing price of $0.21.Atreca, Inc. (BCEL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...The average Terran Orbital stock price prediction forecasts a potential upside of 731.23% from the current LLAP share price of $0.79. What is LLAP's forecast return on equity (ROE) for 2023-2026? (NYSE: LLAP) forecast ROE is N/A, which is considered weak.This reflects a positive earnings surprise of 12.50%. Look out for BCEL's next earnings release expected on November 09, 2023. For the next earning release, we expect the company to report ...Find real-time KR - Kroger Co stock quotes, company profile, news and forecasts from CNN Business.

BCEL stock forecast Our latest prediction for Atreca Inc's stock price was made on the July 20, 2020 when the stock price was at 15.10$.. In the short term (2weeks), BCEL's stock price should outperform the market by 2.41%.During that period the price should oscillate between -10.29% and +13.88%.. In the medium term (3months), BCEL's stock …Atreca Inc (NASDAQ:BCEL) 0.2302. Delayed Data. As of Nov 30. +0.0047 / +2.19%. Today’s Change. 0.19. Today ||| 52-Week Range. 2.05. Next reporting date. December 19, 2023. EPS forecast (this quarter) -$0.08. Annual revenue (last year) $130.5M. Annual profit (last year) -$142.7M. Net profit margin.Explore Atreca, Inc. (BCEL) earnings date, Atreca, Inc. stock earnings history, EPS, estimated EPS, earnings-related price changes, and more.Li Auto Inc - ADR Stock Forecast, LI stock price prediction. Price target in 14 days: 44.695 USD. The best long-term & short-term Li Auto Inc - ADR share price ... BCEL Pre-Market Quotes. Data is delayed at least 15 minutes. Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the ...

Stock Price Forecast. The 8 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 55.00 and a low estimate of 20.00 ...

Analyst Forecast. According to 5 analysts, the average rating for BCEL stock is "Hold." The 12-month stock price forecast is $3.38, which is an increase of 1,479.44% from the latest price.Dec 2, 2023 · The consensus price target of analysts on Wall Street is $2.00, which implies an increase of 89.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $2.00 and $2.00 respectively. As a result, BCEL is trading at a discount of -809.09% off the target high and -809.09% off the low. Track Atreca Inc - Ordinary Shares - Class A (BCEL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsNov 29, 2023 · Qifu Technology (NASDAQ:QFIN) pays an annual dividend of $0.98 per share and currently has a dividend yield of 6.10%. QFIN has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 28.16%. This payout ratio is at a healthy, sustainable level, below 75%. Atreca Inc. Cl A analyst ratings, historical stock prices, earnings estimates & actuals. BCEL updated stock price target summary.The Cymabay Therapeutics Inc stock price gained 6.70% on the last trading day (Friday, 24th Nov 2023), rising from $17.90 to $19.10. During the last trading day the stock fluctuated 6.58% from a day low at $17.92 to a day high of $19.10. The price has risen in 8 of the last 10 days and is up by 28.53% over the past 2 weeks.

See ENTHUSIAST GAMING HOLDINGS INC stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. ... Forecast . Price target. 1.93 0.00 0.00%. The 7 analysts offering 1 year price forecasts for EGLX have a max estimate of — and a min estimate of —.

2010. 90. John Orwin. https://www.atreca.com. Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified ...

The 360 Finance, Inc. stock price fell by -2.78% on the last day (Wednesday, 22nd Nov 2023) from $16.53 to $16.07. During the last trading day the stock fluctuated 4.68% from a day low at $15.81 to a day high of $16.55. The price has risen in 6 of the last 10 days and is up by 4.15% over the past 2 weeks.Atreca Inc (NASDAQ:BCEL) 0.2302. Delayed Data. As of Nov 30. +0.0047 / +2.19%. Today’s Change. 0.19. Today ||| 52-Week Range. 2.05.ADMA Stock 12 Months Forecast. $6.00. (51.90% Upside) Based on 2 Wall Street analysts offering 12 month price targets for ADMA Biologics in the last 3 months. The average price target is $6.00 with a high forecast of $7.00 and a low forecast of $5.00. The average price target represents a 51.90% change from the last price of $3.95.Atreca (BCEL) suspends the development of only pipeline candidate, ATRC-101, in clinical evaluation, as part of its business restructuring efforts and cuts headcount by 40%. The stock falls 37%.Price target. 1.93D CAD +1.58 +451.02%. The 7 analysts offering 1 year price forecasts for ENTHUSIAST GAMING HOLDINGS INC have a max estimate of 2.50 and a min estimate of 1.50.According to analyst projections, BCEL’s forecast low is $1.00 with $9.00 as the target high. To hit the forecast high, the stock’s price needs a -4185.71% plunge from its current level, while the stock would need to soar -376.19% for it to hit the projected low. Atreca Inc (BCEL) estimates and forecastsThe current Atreca [ BCEL] share price is $0.21. The Score for BCEL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. BCEL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.ALEC Stock 12 Months Forecast. $13.78. (169.14% Upside) Based on 9 Wall Street analysts offering 12 month price targets for Alector in the last 3 months. The average price target is $13.78 with a high forecast of $41.00 and a low forecast of $4.00. The average price target represents a 169.14% change from the last price of $5.12.4/13 ratings generated profit. 31%. Average Return. -37.24%. reiterated a buy rating 10 months ago. Copying Do Kim 's trades and holding each position for 1 Year would result in 30.77% of your transactions generating a profit, with an average return of -37.24% per trade. 2 Years. dummy dummy.The BCEL shares have gain 4.62% over the last week, with a monthly amount glided 4.62%, and seem to be holding up well As of right now, Atreca Inc [BCEL] is trading at $0.22, up 2.19%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value.Dec 1, 2023 · 12 analysts have issued twelve-month price objectives for CymaBay Therapeutics' stock. Their CBAY share price targets range from $12.00 to $34.00. On average, they anticipate the company's stock price to reach $22.27 in the next year. This suggests a possible upside of 24.4% from the stock's current price. View analysts price targets for CBAY ...

According to . 3 Wall Street analysts that have issued a 1 year BCEL price target, the average BCEL price target is $9.00, with the highest BCEL stock price forecast at $25.00 and the lowest BCEL stock price forecast at $1.00.February 13, 2024. EPS forecast (this quarter) -$0.20. Annual revenue (last year) $185.3M. Annual profit (last year) -$200.2M. Net profit margin.The average Qifu Technology stock price prediction forecasts a potential upside of 57.86% from the current QFIN share price of $15.52. What is QFIN's forecast return on equity (ROE) for 2023-2025? (NASDAQ: QFIN) forecast ROE is N/A, which is considered weak.Oct 27, 2023 · Forecst.com predicts future values using technical analysis of a large number of analytical parameters. BCEL stock returns are also predicted based on historical data. According to our research, BCEL stock is a bad long-term investment. BCEL share price has been in a bear cycle for the past year. Atreca, Inc. stock trend is negative . Instagram:https://instagram. high dividend reit1921 silver dollars valuebest way to invest in farmland1979 coin value Atreca Inc. Cl A analyst ratings, historical stock prices, earnings estimates & actuals. BCEL updated stock price target summary. benzinga market moversmost expensive house in dubai Find the latest Atreca, Inc. (BCEL) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Based on short-term price targets offered by four analysts, the average price target for Atreca, Inc. comes to $5.25. The forecasts range from a low of $1.00 to a high of $10.00. The average price ... level 2 brokerage account If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.QFIN Stock 12 Months Forecast. $25.75. (85.12% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Qifu Technology in the last 3 months. The average price target is $25.75 with a high forecast of $27.00 and a low forecast of $24.50. The average price target represents a 85.12% change from the last price of $13.91.